Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SPHK2 | Q9NRA0 | 2/20 | 0.30 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19124679 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL23706422 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL23706439 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL19126073 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL23706414 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL23706449 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL23706427 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL23706431 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL23706405 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 | |
| SCHEMBL6037335 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1TSHRSMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015646-A1 | ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIO BATTERY | MURATA MANUFACTURING CO (JP) | 2026-01-15 | — | — | US | disclosed |
| WO-2024209808-A1 | ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIOBATTERY | 株式会社村田製作所 | 2024-10-10 | — | — | WO | disclosed |
| CN-105086446-B | Polymer composition, aligning agent for liquid crystal, liquid crystal orientation film, liquid crystal display element and its manufacturing method and polymer | JSR株式会社 | 2018-08-24 | — | — | CN | disclosed |
| CN-104232107-B | The manufacture method of aligning agent for liquid crystal, phase retardation film and phase retardation film | JSR株式会社 | 2017-09-01 | — | — | CN | disclosed |
| CN-107111191-A | Liquid crystal aligning agent, liquid crystal alignment film, method for producing liquid crystal alignment film, liquid crystal display element, polymer, and compound | JSR株式会社 | 2017-08-29 | — | — | CN | disclosed |
| CN-103289711-B | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | JSR株式会社 | 2017-04-12 | — | — | CN | disclosed |
| CN-103627406-B | Crystal aligning agent, liquid crystal orienting film and liquid crystal display cells | JSR株式会社 | 2016-08-17 | — | — | CN | disclosed |
| CN-105567259-A | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL DISPLAY DEVICE, POLYMER AND COMPOUND | JSR CORP | 2016-05-11 | — | — | CN | disclosed |
| CN-105086446-A | Polymer composition, liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, a manufacturing method of liquid crystal display element, and polymer | JSR CORP | 2015-11-25 | — | — | CN | disclosed |
| CN-102236209-B | Producing method of liquid crystal display element, polymer composition and liquid crystal display element | JSR CORP | 2015-02-25 | — | — | CN | disclosed |
| CN-103937510-A | Liquid crystal alignment agent for PSA (Polymer Sustained Alignment) liquid crystal display component and application thereof | JSR CORP | 2014-07-23 | — | — | CN | disclosed |
| CN-103834415-A | Liquid crystal aligning agent, phase difference film and manufacturing method for the phase difference film | JSR CORP | 2014-06-04 | — | — | CN | disclosed |
| CN-103788962-A | Liquid crystal aligning agent for PSA mode liquid crystal display device, liquid crystal alignment film for PSA mode liquid crystal display device, and the PSA mode liquid crystal display device and manufacturing method thereof | JSR CORP | 2014-05-14 | — | — | CN | disclosed |
| CN-102041007-B | Liquid crystal aligning agent, liquid crystal display element and polyorganosiloxane compound | JSR CORP | 2014-03-19 | — | — | CN | disclosed |
| CN-103627406-A | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | JSR CORP | 2014-03-12 | — | — | CN | disclosed |
| CN-103525436-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device | JSR CORP | 2014-01-22 | — | — | CN | disclosed |
| CN-103289711-A | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | JSR CORP | 2013-09-11 | — | — | CN | disclosed |
| CN-102629030-A | Liquid crystal display element and manufacturing method thereof, and liquid crystal orientation agent | JSR CORP | 2012-08-08 | — | — | CN | disclosed |
| CN-102236209-A | Producing method of liquid crystal display element, polymer composition and liquid crystal display element | JSR CORP | 2011-11-09 | — | — | CN | disclosed |
| CN-102041007-A | Liquid crystal aligning agent, liquid crystal display element and polyorganosiloxane compound | JSR CORP | 2011-05-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015646-A1 | ENZYME ELECTRODE, METHOD FOR PRODUCING ENZYME ELECTRODE, BIOSENSOR, AND BIO BATTERY | SORD, NQO1, PDHB | ALDH1A1 92/4885TDP1 1919/4885TSHR 3339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.